Fragments of prochymosin produced in Escherichia coli form insoluble inclusion bodies
- 1 February 1989
- journal article
- research article
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 171 (2) , 1225-1227
- https://doi.org/10.1128/jb.171.2.1225-1227.1989
Abstract
Bovine prochymosin produced in Escherichia coli has been used as a model system to investigate factors which may cause a recombinant protein to accumulate as insoluble inclusion bodies. A series of plasmids was constructed to investigate the effect of deletions within the prochymosin-coding sequence on protein inclusion body formation. The results demonstrated that as much as 70% of the prochymosin-coding sequence could be deleted with no significant reduction in the accumulation of insoluble protein. The smallest deletion product identified (11,000 molecular weight) retained only one cysteine, yet this product still accumulated as an insoluble product in E. coli.This publication has 13 references indexed in Scilit:
- Unusual zymogen‐processing properties of a mutated form of prochymosinProteins-Structure Function and Bioinformatics, 1988
- Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDaAnalytical Biochemistry, 1987
- A mutated bovine prochymosin zymogen can be activated without proteolytic processing at low pH.Journal of Biological Chemistry, 1986
- Recovery of soluble human renin from inclusion bodies produced in recombinant Escherichia coliJournal of Biotechnology, 1986
- Enzymatic properties and processing of bovine prochymosin synthesized in Escherichia coliJournal of Biotechnology, 1985
- Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencingGene, 1984
- Synthesis of calf prochymosin (prorennin) in Escherichia coli.Proceedings of the National Academy of Sciences, 1983
- Cytoplasmic Inclusion Bodies in Escherichia coli Producing Biosynthetic Human Insulin ProteinsScience, 1982
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977